Search results
A little-understood sleep disorder affects millions and has clear links to dementia – 4 questions...
The Conversation via Yahoo News· 1 day agoThe disorder, known as REM sleep behavior disorder, or RBD in the medical field, affects around 1%...
Therapeutic target identified to neutralize toxic forms of Parkinson's-associated protein
Medical Xpress· 3 hours agoAlpha-synuclein aggregation is a hallmark of Parkinson's disease and other synucleinopathies. It is a dynamic process in which the protein ...
Michael J. Fox
Time Magazine· 4 days agoIt’s been a long time since there was good news about Parkinson’s disease, a neurodegenerative condition that affects ...
Web platform and app aim to improve quality of life for people with Parkinson's disease
Medical Xpress· 4 days agoParkinson's disease is one of the most prevalent neurodegenerative conditions worldwide. Memory can also worsen as the disease ...
Early voting begins for Virginia’s June congressional primaries
Virginia Mercury via Yahoo News· 9 hours agoVirginia’s 45-day early voting window began Friday for the June 18 primaries that will set the stage...
IRLAB has Received Approval from the Swedish Medical Products Agency to Conduct a Phase I Study of...
Digital Journal· 14 hours agoIRL757 is being developed as a treatment to...
Annovis Bio CEO Maria Maccecchini Issues Letter to Stockholders - Annovis Bio (NYSE:ANVS)
Benzinga· 8 hours agoAnnovis Bio, Inc. ANVS ("Annovis" or the "Company"), a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases, announced ...
NKGen Biotech gears up for Parkinson's trial after FDA nod By Investing.com
Investing.com· 7 days agoNKGen Biotech, Inc. (NASDAQ: NKGN), a clinical-stage biotech company, has received clearance from...
What is dementia? Types, symptoms, causes and treatment
The Telegraph via Yahoo News· 1 day agoBy the year 2040, there will be 1.7 million people in the UK living with dementia, according to the...
Anavex Life Sciences to Announce Fiscal 2024 Second Quarter Financial Results on Thursday, May 9th,...
Morningstar· 4 days ago(“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental ...